Update on strongyloidiasis in the immunocompromised host

被引：105
作者：
Marcos L.A. [1 ,2 ]
Terashima A. [2 ,3 ]
Canales M. [2 ,3 ]
Gotuzzo E. [2 ,3 ]
机构：
[1] Internal Medicine Department, School of Medicine, Washington University, St. Louis, MO 63110
[2] Institute of Tropical Medicine Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima
[3] Lima 100
来源：
Current Infectious Disease Reports | 2011年 / 13卷 / 1期
关键词：
Agar plate; Anthelminthic; Autoinfection; Dissemination; Hyperinfection syndrome; Immigrant; Immunocompromised host; Ivermectin; Parenteral; Strongyloides stercoralis; Strongyloidiasis; Transplant population; USA;
D O I：
10.1007/s11908-010-0150-z
中图分类号：
学科分类号：
摘要：
Immunocompromised persons are the most vulnerable population at risk for developing life-threatening clinical syndromes associated with strongyloidiasis, such as hyperinfection syndrome (HS) or dissemination. This review focuses on describing Strongyloides infection in the immunocompromised host, including immune response against this infection, analyzing the cases with HS published during the past 4 years in the United States, and describing the most sensitive diagnostic tools and the most effective treatment for each clinical syndrome. Strongyloidiasis is becoming an important parasitic disease in the United States, especially in the immunocompromised immigrant population. Because the transplant population is particularly at risk for developing HS, both recipients and donors should be screened for Strongyloides. Clinicians should also be aware that the development of HS can follow unexpectedly a few days after appropriate anthelminthic therapy. Highly sensitive screening tests are still not available in the major tertiary medical centers. Parenteral ivermectin has been used in some severe cases. Further therapy developments and improving diagnostic tools are warranted. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码：35 / 46
页数：11
相关论文
共 113 条
  • [1] Bethony J., Brooker S., Albonico M., Et al., Soil-transmitted helminth infections: Ascariasis, trichuriasis, and hookworm, Lancet, 367, pp. 1521-1532, (2006)
  • [2] Marcos L.A., Terashima A., Dupont H.L., Gotuzzo E., Strongyloides hyperinfection Syndrome: An Emerging Global Infectious Disease, Trans R Soc Trop Med Hyg, 102, pp. 314-318, (2008)
  • [3] Genta R.M., Dysregulation of strongyloidiasis: A new hypothesis, Clin Microbiol Rev., 5, pp. 345-355, (1992)
  • [4] Croker C., Reporter R., Redelings M., Mascola L., Strongyloidiasis-related deaths in the United States, 1991-2006, Am. J. Trop. Med. Hyg, 83, pp. 422-426, (2010)
  • [5] Jankovic D., Steinfelder S., Kullberg M., Sher A., Mechanisms underlying helminth-induced Th2 polarization: Default, negative or positive pathways? In: Capron, M. Trottein, F. (Eds.), Parasites and Allergy, Chem. Immunol., 90, pp. 65-81, (2006)
  • [6] Finkelman F.D., Shea-Donohue T., Goldhill J., Sullivan C.A., Morris S.C., Madden K.B., Gause W.C., Urban Jr. J.F., Cytokine regulation of host defense against parasitic gastrointestinal nematodes: Lessons from studies with rodent models, Annual Review of Immunology, 15, pp. 505-533, (1997)
  • [7] Ilic N., Colic M., Gruden-Movsesijan A., Et al., Characterization of rat bone marrow dendritic cells initially primed by Trichinella spiralis antigens, Parasite Immunol., 30, pp. 491-495, (2008)
  • [8] Wilkes C.P., Bleay C., Paterson S., Viney M.E., The immune response during a Strongyloides ratti infection of rats, Parasite Immunology, 29, 7, pp. 339-346, (2007)
  • [9] Abe H., Sugaya K., Ishida W.I., Et al., Intestinal protection against Strongyloides ratti and mastocytosis induced by administration of interleukin-3 in mice, Immunology, 80, pp. 116-121, (1993)
  • [10] Artis D., Grencis R.K., T helper cell cytokine responses during intestinal nematode infection: Induction, regulation and effector function, Parasitic, pp. 331-371, (2001)
12345678910